Patents-Review.com
ClassID:

20473 ⎘

A61K31/569 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone

Recent Application in this class:
#1
20260083668
2026-03-26

ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS

 #2
20260048009
2026-02-19

EUTECTIC SOLVENTS COMPRISING PHARMACEUTICAL AGENTS, AND METHODS OF MAKING AND USE THEREOF

 #3
20260021110
2026-01-22

METHODS OF ORAL CONTRACEPTION BY CONTROLLED RELEASE OF DIENOGEST AND ETHYNYL ESTRADIOL

 #4
20260021041
2026-01-22

ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS

 #5
20250345334
2025-11-13

METHODS OF TREATING PROSTATE CANCER

 #6
20250249023
2025-08-07

INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE

 #7
20250144040
2025-05-08

COMPOSITE PARTICLE FORMULATIONS AND APPLICATIONS THEREOF

 #8
20250082870
2025-03-13

PHARMACEUTICAL ADMINISTRATION TO NEONATES, INFANTS AND CHILDREN

 #9
20250073246
2025-03-06

METHOD OF TREATING HYPOGONADISM IN MEN

 #10
20250041208
2025-02-06

NEW INJECTABLE COMBINATION FORMULATION

 #11
20240366729
2024-11-07

COMBINATION OF A NURR1 AGONIST WITH AT LEAST ONE OF AN ALDOSTERONE ANTAGONIST, AN INSULIN MODULATOR AND A SULFONYLUREA

 #12
20240358715
2024-10-31

METHODS OF REDUCING MAMMOGRAPHIC BREAST DENSITY AND/OR BREAST CANCER RISK

 #13
20240350626
2024-10-24

METHODS FOR TREATING EOSINOPHILIC GASTROENTERITIS BY ADMINISTERING AN IL-4R ANTAGONIST

 #14
20240226116
2024-07-11

Glucocorticoid Particles and Their Use

 #15
20240115508
2024-04-11

Nanocrystals, compositions, and methods that aid particle transport in mucus

 #16
20240091148
2024-03-21

EUTECTIC SOLVENTS COMPRISING PHARMACEUTICAL AGENTS, AND METHODS OF MAKING AND USE THEREOF

 #17
20240065969
2024-02-29

OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF

 #18
20240033222
2024-02-01

AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE

 #19
20240009206
2024-01-11

Steroidal Compositions

 #20
20230398129
2023-12-14

CRYSTAL-FREE HIGH-CONCENTRATION TESTOSTERONE CYPIONATE FORMULATIONS

 #21
20230285282
2023-09-14

OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT

 #22
20230285278
2023-09-14

METHODS FOR TREATING CHRONIC RHINOSINUSITIS

 #23
20230255983
2023-08-17

Inhalable formulation of fluticasone propionate and albuterol sulfate

 #24
20230218667
2023-07-13

Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

 #25
20230218634
2023-07-13

METHODS OF TREATING CASTRATION-RESISTANT PROSTATE CANCER WITH GLUCOCORTICOID RECEPTOR ANTAGONISTS AND ANTI-ANDROGEN RECEPTOR THERAPY AND ANTI-ANDROGEN RECEPTOR THERAPY

 #26
20230181598
2023-06-15

FORMULATIONS AND METHODS OF TREATING COVID-19 AND PREVENTING INFECTION WITH SARS-CoV-2

 #27
20230181555
2023-06-15

STABLE AND PRESERVED PHARMACEUTICAL COMPOSITIONS OF BILASTINE

 #28
20230157965
2023-05-25

Nanocrystals, compositions, and methods that aid particle transport in mucus

 #29
20230149429
2023-05-18

Use of a nitrogen-containing bisphosphonate in combination with a glucocorticoid in preventing or treating viral pneumonia

 #30
20230119239
2023-04-20

OROMUCOSAL FILM COMPOSITIONS

 #31
20230091716
2023-03-23

Progesterone Combinations

 #32
20230091568
2023-03-23

Ophthalmic drug sustained release formulation and uses thereof

 #33
20230029033
2023-01-26

Inhalers and related methods

 #34
20230012966
2023-01-19

Inhalers and related methods

 #35
20220387389
2022-12-08

DEVICE FOR INTERNAL AND EXTERNAL NASAL APPLICATION

 #36
20220387388
2022-12-08

SKIN-CARE BALM AND DEVICE FOR INTERNAL AND EXTERNAL NASAL APPLICATION

 #37
20220339098
2022-10-27

Orally administered corticosteroid compositions

 #38
20220323352
2022-10-13

PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS

 #39
20220296521
2022-09-22

CARRIER-BASED FORMULATIONS AND RELATED METHODS

 #40
20220241296
2022-08-04

PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS

 #41
20220202829
2022-06-30

NON-IRRITATING TESTOSTERONE EMULSIONS

 #42
20220168319
2022-06-02

COMBINED USE OF A-NOR-5alpha ANDROSTANE COMPOUND DRUG AND ANTICANCER DRUG

 #43
20220133785
2022-05-05

Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

 #44
20220079954
2022-03-17

Methods of reducing mammographic breast density and/or breast cancer risk

 #45
20220072009
2022-03-10

SHORT-ACTING SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS

 #46
20220047610
2022-02-17

Inhalable formulation of fluticasone propionate and albuterol sulfate

 #47
20220040202
2022-02-10

INHIBITORS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE FOR TREATING CARDIOVASCULAR AND PULMONARY CONDITIONS

 #48
20220008666
2022-01-13

Pharmaceutical administration to neonates, infants and children

 #49
20210401855
2021-12-30

PHARMACEUTICAL FORMULATION CONTAINING COMBINATION OF M3 ANTAGONIST-BETA-2 AGONIST AND INHALED CORTICOSTEROIDS

 #50
20210369734
2021-12-02

COMPOUNDS AND METHODS OF THEIR USE

 #51
20210369606
2021-12-02

Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent

 #52
20210322546
2021-10-21

METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST

 #53
20210315906
2021-10-14

Botanical extracts and compounds from Schinus plants and methods of use

 #54
20210308048
2021-10-07

EUTECTIC SOLVENTS COMPRISING PHARMACEUTICAL AGENTS, AND METHODS OF MAKING AND USE THEREOF

 #55
20210290617
2021-09-23

Ophthalmic formulations of cetirizine and methods of use

 #56
20210284742
2021-09-16

METHODS OF TREATING OR PREVENTING MUCORMYCOSIS

 #57
20210268002
2021-09-02

ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION

 #58
20210244660
2021-08-12

Orally administered corticosteroid compositions

 #59
20210177865
2021-06-17

Steroidal Compositions

 #60
20210137888
2021-05-13

NOVEL COMBINATION PRODUCT

 #61
20210128483
2021-05-06

Nanocrystals, compositions, and methods that aid particle transport in mucus

 #62
20210113588
2021-04-22

NON-IRRITATING TESTOSTERONE EMULSIONS

 #63
20210100816
2021-04-08

Steroidal Compositions

 #64
20210069212
2021-03-11

Anordrin compositions and methods for treating diseases

 #65
20210046018
2021-02-18

RESVERATROL MEDICATION FOR THE TREATMENT OF OCULAR PAIN AND METHOD OF USE THEREOF

 #66
20210038615
2021-02-11

Steroidal compositions

 #67
20200405711
2020-12-31

Ophthalmic formulations of cetirizine and methods of use

 #68
20200383999
2020-12-10

STEROIDAL COMPOSITIONS

 #69
20200375918
2020-12-03

Compositions for the treatment of blepharitis

 #70
20200368153
2020-11-26

Eye drop formulation and method for sustained delivery of medicament to the retina

 #71
20200330482
2020-10-22

Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists and anti-androgen receptor therapy

 #72
20200306262
2020-10-01

COMPOUNDS AND METHODS OF THEIR USE

 #73
20200297719
2020-09-24

Ophthalmic formulations of cetirizine and methods of use

 #74
20200289527
2020-09-17

FORMULATION CONTAINING A-DECARBONIZED-5a ANDROSTANE COMPOUND FOR INCREASING WHITE BLOOD CELL AND USE THEREOF

 #75
20200253984
2020-08-13

Methods of reducing mammographic breast density and/or breast cancer risk

 #76
20200246355
2020-08-06

Glucocorticoid “nintedanib” particles and their use

 #77
20200222317
2020-07-16

Ophthalmic drug sustained release formulation and uses thereof

 #78
20200214979
2020-07-09

Orally administered corticosteroid compositions

 #79
20200155569
2020-05-21

Compositions comprising triterpenoids

 #80
20190321373
2019-10-24

Methods of reducing mammographic breast density and/or breast cancer risk

 #81
20190314389
2019-10-17

Compositions comprising triterpenoids

 #82
20190290659
2019-09-26

Inhibitors of glucose-6-phosphate dehydrogenase for treating cardiovascular and pulmonary conditions

 #83
20190282601
2019-09-19

PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE

 #84
20190262360
2019-08-29

Anordrin compositions and methods for treating diseases

 #85
20190255069
2019-08-22

Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists after anticancer therapy

 #86
20190224216
2019-07-25

Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy

 #87
20190209706
2019-07-11

Composition for improving the solubility of poorly soluble substances, use thereof and complex formulation containing thereof

 #88
20190209582
2019-07-11

Compositions comprising triterpenoids

 #89
20190192538
2019-06-27

Botanical extracts and compounds from plants and methods of use

 #90
20190175496
2019-06-13

Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent

 #91
20190167926
2019-06-06

Inhalers and Related Methods

 #92
20190167697
2019-06-06

Methods of reducing mammographic breast density and/or breast cancer risk

 #93
20190125865
2019-05-02

METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST

 #94
20190099388
2019-04-04

Topical compositions and methods for making and using same

 #95
20190076444
2019-03-14

Compositions comprising acidic extracts of mastic gum

 #96
20190015609
2019-01-17

Inhalers and Related Methods

 #97
20180280383
2018-10-04

Ophthalmic formulations of cetirizine and methods of use

 #98
20180264006
2018-09-20

Compositions comprising triterpenoids

 #99
20180263899
2018-09-20

Intrauterine delivery system for contraception

 #100
20180256508
2018-09-13

Nanocrystals, compositions, and methods that aid particle transport in mucus

 #101
20180228989
2018-08-16

Inhalers and related methods

 #102
20180228986
2018-08-16

Inhalers and related methods

 #103
20180221388
2018-08-09

Non-irritating testosterone emulsions

 #104
20180177801
2018-06-28

Application of antidepressant compound in preparation of antidepressant drugs and antidepressant health-care foods

 #105
20180153802
2018-06-07

Orally administered corticosteroid compositions

 #106
20180104193
2018-04-19

Transdermal Delivery

 #107
20180092836
2018-04-05

Ophthalmic drug sustained release formulation and uses thereof

 #108
20180036319
2018-02-08

TRANSDERMAL DRUG DELIVERY SYSTEMS FOR NORETHINDRONE ACETATE

 #109
20180036318
2018-02-08

Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists

 #110
20170368076
2017-12-28

Compositions comprising acidic extracts of mastic gum

 #111
20170354663
2017-12-14

Steroidal Compositions

 #112
20170333445
2017-11-23

Methods of reducing mammographic breast density and/or breast cancer risk

 #113
20170312219
2017-11-02

METHOD OF CONTRACEPTION

 #114
20170252357
2017-09-07

Steroidal Compositions

 #115
20170246185
2017-08-31

Methods of reducing mammographic breast density and/or breast cancer risk

 #116
20170232032
2017-08-17

Pharmaceutical compositions for treating ebola virus disease

 #117
20170216313
2017-08-03

Oral formulation of A-nor-5α androstane compound

 #118
20170216312
2017-08-03

STERODIAL COMPOSITIONS

 #119
20170189412
2017-07-06

Androgen composition for treating an ophthalmic condition

 #120
20170188814
2017-07-06

Inflammatory eye disorders

 #121
20170182035
2017-06-29

Ophthalmic formulations of cetirizine and methods of use

 #122
20170172943
2017-06-22

Topical compositions and methods for making and using same

 #123
20170151263
2017-06-01

Anordrin compositions and methods for treating diseases

 #124
20170112948
2017-04-27

Inorganic-organic hybrid compound

 #125
20170071855
2017-03-16

Orally administered corticosteroid compositions

 #126
20170042830
2017-02-16

FILM DELIVERY SYSTEM FOR ACTIVE INGREDIENTS

 #127
20170027865
2017-02-02

Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders

 #128
20160287611
2016-10-06

METHODS, COMPOSITIONS, AND FORMULATIONS FOR THE TREATMENT OF THYROID EYE DISEASE

 #129
20160287526
2016-10-06

Nanocrystals, compositions, and methods that aid particle transport in mucus

 #130
20160271145
2016-09-22

METHOD FOR ENLARGING THE PARTICLE SIZE OF CRYSTALLINE MICROPARTICLES OF ACTIVE SUBSTANCE

 #131
20160199389
2016-07-14

Compositions comprising acidic extracts of mastic gum

 #132
20160184322
2016-06-30

USE OF ent-PROGESTERONE TO BETTER OUTCOMES ASSOCIATED WITH TBI AND mTBI

 #133
20160175572
2016-06-23

Device and method for sustained release of low water solubility therapeutic agent in solubilizer

 #134
20160151588
2016-06-02

Pharmaceutical Metered Dose Inhaler and Methods Relating Thereto

 #135
20160151388
2016-06-02

Method of treatment for prostate cancer with androgen receptor antagonists and glucocorticoid receptor antagonists

 #136
20160106666
2016-04-21

Ophthalmic formulations of cetirizine and methods of use

 #137
20160081915
2016-03-24

TRANSDERMAL FORMULATIONS OF FLUTICASONE

 #138
20160045451
2016-02-18

Transdermal contraceptive hormones delivery

 #139
20160008777
2016-01-14

PHARMACEUTICAL COMPOUNDING KIT

 #140
20160000706
2016-01-07

Core sheath drug delivery devices

 #141
20150366800
2015-12-24

Androgen composition for treating an opthalmic condition

 #142
20150328233
2015-11-19

Solid oral dosage form of testosterone derivative

 #143
20150320816
2015-11-12

COMPOSITIONS FOR PROMOTION OF WOUND HEALING AND/OR SCAR REDUCTION

 #144
20150313841
2015-11-05

Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseases

 #145
20150313836
2015-11-05

Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders

 #146
20150265543
2015-09-24

Nanocrystals, compositions, and methods that aid particle transport in mucus

 #147
20150265542
2015-09-24

Nanocrystals, compositions, and methods that aid particle transport in mucus

 #148
20150246119
2015-09-03

Methods for treating or preventing asthma by administering an IL-4R antagonist

 #149
20150224197
2015-08-13

INHALATION COMPOSITIONS

 #150
20150157567
2015-06-11

Inhalation compositions comprising muscarinic receptor antagonist

 #151
20150157561
2015-06-11

Intravaginal ring drug delivery system

 #152
20150099726
2015-04-09

Dry powder inhaler

 #153
20150031614
2015-01-29

Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor

 #154
20150025051
2015-01-22

FORMULATIONS FOR TREATING SKIN DISORDERS

 #155
20150010503
2015-01-08

Method of treatment of prostate cancer with androgen receptor and glucocorticoid receptor antagonists

 #156
20140378424
2014-12-25

ESTROGEN RECEPTOR MODULATORS FOR REDUCING BODY WEIGHT

 #157
20140342001
2014-11-20

MEDICAMENTS

 #158
20140315872
2014-10-23

Non-irritating testosterone emulsions

 #159
20140303131
2014-10-09

Orally administered corticosteroid compositions

 #160
20140287053
2014-09-25

Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith

 #161
20140287051
2014-09-25

Orally administered corticosteroid compositions

 #162
20140271819
2014-09-18

Onapristone polymorphic forms and methods of use

 #163
20140234225
2014-08-21

METHOD OF TREATMENT USING NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER

 #164
20140213564
2014-07-31

Topical compositions and methods for making and using same

 #165
20140199244
2014-07-17

Controlled release system

 #166
20140193519
2014-07-10

INDIBULIN THERAPY

 #167
20140179655
2014-06-26

SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE

 #168
20140134254
2014-05-15

Method for producing powders for inhalation

 #169
20140127280
2014-05-08

Intrauterine delivery system for contraception

 #170
20140004171
2014-01-02

Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent

 #171
20130345455
2013-12-26

Methods of preparing pharmaceutical solid state forms

 #172
20130345184
2013-12-26

PHARMACEUTICAL SOLID STATE FORMS-2

 #173
20130338125
2013-12-19

TREATMENT METHODS USING PHARMACEUTICAL SOLID STATE FORMS

 #174
20130269706
2013-10-17

Barrel-shaped vaginal ring

 #175
20130224123
2013-08-29

Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer

 #176
20130209539
2013-08-15

Core sheath drug delivery devices

 #177
20130116217
2013-05-09

Neuroprotection and myelin repair using nestorone®

 #178
20120322780
2012-12-20

Steroidal compositions

 #179
20120316144
2012-12-13

ANTIFUNGAL AGENT

 #180
20120309730
2012-12-06

OXYSTEROLS THAT ACTIVATE LIVER X RECEPTOR SIGNALING AND INHIBIT HEDGEHOG SIGNALING

 #181
20120225853
2012-09-06

HORMONE REPLACEMENT THERAPY AND DEPRESSION

 #182
20120190661
2012-07-26

Androgen composition for treating an opthalmic condition

 #183
20120028935
2012-02-02

Therapeutic Gestagens for the Treatment of Premenstrual Dysphoric Disorder

 #184
20120021041
2012-01-26

Contraceptive transdermal delivery of hormones

 #185
20120015917
2012-01-19

Use of Estrogenic Compounds in Combination with Progestogenic Compounds in Hormone-Replacement Therapy

 #186
20120004204
2012-01-05

Methods for treating sexual dysfunction while decreasing cardiovascular risk

 #187
20110319352
2011-12-29

Compounds That Bind Oxysterol Binding Proteins, and Methods of Use Thereof

 #188
20110294771
2011-12-01

Treatment of muscular dystrophy

 #189
20110146693
2011-06-23

INTRAUTERINE DELIVERY SYSTEM FOR CONTRACEPTION

 #190
20110144072
2011-06-16

Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

 #191
20110137057
2011-06-09

Unsaturated steroid compounds

 #192
20110124613
2011-05-26

Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma

 #193
20110081411
2011-04-07

Orally administered corticosteroid compositions

 #194
20110046099
2011-02-24

STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM

 #195
20110046095
2011-02-24

STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM

 #196
20100240625
2010-09-23

Ophthalmic formulations of cetirizine and methods of use

 #197
20100227841
2010-09-09

Patient populations and treatment methods

 #198
20100222315
2010-09-02

Patient populations and treatment methods

 #199
20100222308
2010-09-02

OPHTHALMIC, OTIC OR NASAL PHARMACEUTICAL COMPOSITION AND THE USE THEREOF

 #200
20100173882
2010-07-08

Steroidal compositions

 #201
20100137267
2010-06-03

FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE, CUTANEOUS TISSUE AND DISORDERS, AND MUSCULAR TISSUE

 #202
20100137265
2010-06-03

Treatment of conditions relating to hormone deficiencies by administration of progestins

 #203
20100136121
2010-06-03

MEDICAMENTS

 #204
20100135956
2010-06-03

STEROID MODULATORS OF PROGESTERONE RECEPTOR AND/OR GLUCOCORTICOID RECEPTOR

 #205
20100119609
2010-05-13

METHODS, COMPOSITIONS, AND FORMULATIONS FOR THE TREATMENT OF THYROID EYE DISEASE

 #206
20100113405
2010-05-06

METHYLINDAZOLE MODULATORS OF 5-HT3 RECEPTORS

 #207
20100086586
2010-04-08

Pharmaceutical Composition

 #208
20100075936
2010-03-25

USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS FOR TREATMENT OF INFECTIOUS CONDITIONS

 #209
20090312296
2009-12-17

ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES

 #210
20090291932
2009-11-26

Pharmaceutical solid state forms

 #211
20090081303
2009-03-26

Pharmaceutical formulation for contraception and hormone-replacement therapy

 #212
20090074875
2009-03-19

Nanoparticulate compositions having lysozyme as a surface stabilizer

 #213
20090029959
2009-01-29

Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants

 #214
20080306039
2008-12-11

Loteprednol Etabonate Aqueous Suspension

 #215
20080300224
2008-12-04

Treatment of conditions relating to hormone deficiencies by administration of progestins

 #216
20080241274
2008-10-02

Indibulin therapy

 #217
20080234240
2008-09-25

Extended Use Combination Comprising Estrogens And Progestins

 #218
20080206310
2008-08-28

Regimens for Controlled Drug Delivery Devices for Contraception

 #219
20080190418
2008-08-14

Pharmaceutical Metered Dose Inhaler and Methods Relating Thereto

 #220
20070196459
2007-08-23

Compositions and methods for treating dermatitis or psoriasis

 #221
20070190120
2007-08-16

Administration of non-oral androgenic steroids to women

 #222
20070185068
2007-08-09

Use of sex steroid function modulators to treat wounds and fibrotic disorders

 #223
20070077201
2007-04-05

Stem cell expansion and uses

 #224
20070071691
2007-03-29

Composition

 #225
20070027201
2007-02-01

Use of progesterone receptor modulators

 #226
20070014719
2007-01-18

Steroid analogs and characterization and treatment methods

 #227
20070004690
2007-01-04

Quadraphasis continuous graduated estrogen contraceptive

 #228
20060292085
2006-12-28

Medicaments

 #229
20060094698
2006-05-04

Self-administered contraceptive injection of oily solution

 #230
20060068389
2006-03-30

Methods and compositions for inhibiting hiv replication

 #231
20060051420
2006-03-09

Pharmaceutical tablets containing tibolone and a coating

 #232
20060003977
2006-01-05

Tibolone-adsorbates

 #233
20050282790
2005-12-22

Therapeutic gestagens for the treatment of premenstrual dysphoric disorder

 #234
20050222114
2005-10-06

Use of new etonogestrel esters

 #235
20050176679
2005-08-11

Process for the preparation of free flowing pulverized adsorbates of tibolone

 #236
20050148559
2005-07-07

Method of preventing or treating benign gynaecological disorders

 #237
20050085445
2005-04-21

Cyclodextrines for use as suspension stabilizers in pressure-liquefied propellants

 #238
20050080061
2005-04-14

Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

 #239
20050032758
2005-02-10

Hormone replacement therapy and depression

 #240
20050025827
2005-02-03

Pharmaceutical formulation for contraception and hormone-replacement therapy

 #241
20050020553
2005-01-27

Prevention of miscarriage with immunomodulating non-endogenous gestagen compounds

 #242
20050014735
2005-01-20

Treatment of Th2 dominated immunological disease states with progesterone receptor antagonists

 #243
20050014731
2005-01-20

Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds